Abstract
The T-cell subpopulations which initiate and mediate tissue allograft rejection remain controversial1–5. In the present study we attempted to identify the phenotype and function of the T-cell subset(s) primarily responsible for the rejection of skin allografts differing at a single class I locus in the major histocompatibility complex (MHC). We found that the rejection rates by B6 mice (H–2b) of four different class I mutant (Kbm) skin allografts form a distinct hierarchy. This hierarchy correlates strikingly and uniquely with the relative precursor frequencies of Lyt2+ interleukin-2-secreting T-helper cells reactive against the various Kbm mutants. To investigate the role of Lyt2+ T cells in the rejection of class I-disparate skin allografts directly, H–2b nude mice were engrafted with Kbm skin allografts and then reconstituted with L3T4+ or Lyt2+ T-cell subpopulations from syngeneic H–2b mice. Lyt2+ T cells were observed to be both necessary and sufficient for the rejection of class I-disparate Kbm skin allografts, whereas L3T4+ T cells were neither necessary nor sufficient. These results identify the Lyt2+ interleukin-2-secreting T-cell subset as the critical cell type determining the rejection rate of class I-disparate Kbm skin allografts.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Loveland, B. E., Hogarth, P. M., Ceredig, R. H. & McKenzie, I. F. C. J. exp. Med. 153, 1044–1057 (1981).
LeFrancois, L. & Bevan, M. J. J. exp. Med. 159, 57–67 (1984).
Hall, B. M. & Dorsch, S. E. Immun. Rev. 77, 31–59 (1984).
Lafferty, K. J. & Simeonovic, C. J. Transplantn Proc. 16, 927–930 (1984).
Steinmuller, D. Transplantation 40, 229–233 (1985).
Melvold, R. W. & Kohn, H. I. Immunogenetics 3, 185–191 (1976).
Kohn, H. I. et al. Immunogenetics 77, 279–294 (1978).
Nairn, R., Yamaga, K. & Nathenson, S. G. A. Rev. Genet. 14, 241–277 (1980).
Melief, C. J. M., Schwartz, R. S., Kohn, H. I. & Melvold, R. W. Immunogenetics 2, 337–348 (1975).
Melief, C. J. M., de Waal, L. P., van der Meulen, M. Y., Melvold, R. W. & Kohn, H. I. J. exp. Med. 151, 993–1013 (1980).
Mizuochi, T., Ono, S., Malek, T. R. & Singer, A. J. exp. Med. 163, 603–619 (1986).
Golding, H. & Singer, A. J. Immun. 135, 1610–1615 (1985).
Singer, A., Kruisbeek, A. M. & Andrysiak, P. M. J. Immun. 132, 2199–2209 (1984).
Golding, H. & Singer, A. J. Immun. 133, 597–605 (1984).
Mizuochi, T. et al. J. exp. Med. 162, 427–433 (1985).
Mizuochi, T. et al. J. Immun. (in the press).
Lynch, D. H., Weiland, D. J., Rosenberg, S. A. & Hodes, R. J., Transplantation (in the press).
Engers, H. D., Galsebrook, A. L. & Sorenson, G. D. J. exp. Med. 156, 1280–1285 (1982).
Engers, H. D., Sorenson, G. S., Geronimo, T., Horvath, C. & Brunner, K. T. J. Immun. 129, 1292–1298 (1982).
Hodgkin, P. D., Agostino, M. & Lafferty, K. J. Transpln Proc. 17, 1644–1645 (1985).
Warren, H. S., Prouse, S. J., Agostino, M. & Lafferty, K. J. Transpln Proc. 16, 954–955 (1984).
Sprent, J., Schaefer, M., Lo, D. & Korngold, R. J. exp. Med. 163, 998–1011 (1986).
Weinberger, O., Germain, R. N. & Burakoff, S. J. Nature 302, 429–431 (1983).
Caughman, S. W. et al. Proc. natn. Acad. Sci. U.S.A. (in the press).
Malek, T. R., Robb, R. J. & Shevach, E. M. Proc. natn. Acad. Sci. U.S.A. 80, 5694–5698 (1983).
Watson, J. J. exp. Med. 150, 1510–1519 (1979).
Taswell, C. J. Immun. 126, 1614–1619 (1981).
Kruisbeek, A. M., Zystra, J. J. & Krose, T. J. M. J. Immun. 125, 995–1002 (1980).
Billingham, R. E. & Medawar, P. B. J. exp. Biol. 28, 385–401 (1951).
Dialynas, D. P. et al. Immun. Rev. 74, 29–56 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosenberg, A., Mizuochi, T. & Singer, A. Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC. Nature 322, 829–831 (1986). https://doi.org/10.1038/322829a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/322829a0
This article is cited by
-
Transplantation tolerance—where do we stand?
Nature Medicine (1999)
-
Identification of an HLA-DQ6-derived peptide recognized by mouse MHC class I H-2Db-restricted CD8+ T cells in HLA-DQ6 transgenic mice
Japanese Journal of Human Genetics (1997)
-
Induction of cytotoxic T lymphocytes specific to the molecule of the class I major histocompatibility complex for subcutaneous immunization in pads
Bulletin of Experimental Biology and Medicine (1995)
-
T lymphocyte effector mechanisms in the retina in posterior uveitis
Eye (1994)
-
T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection
Immunologic Research (1989)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.